Stroke Detection Innovator Wellumio Expands into the U.S. Market
Revolutionary portable device leverages advanced magnetic resonance technology to rapidly detect acute stroke biomarkers, enabling frontline care teams to make faster,...
Healthcare
PBS Biotech Expands Leadership Team and Secures $17 Million in Growth Capital to Accelerate Delivery of Next Generation Cell and Regenerative Therapies
Proceeds from the financing will be used to broaden and improve the company's offerings and for operational expansion across facilities,...
Addtronics Announces Appointment of Adam Meyers to Board
GREENWICH, Conn., Jan. 6, 2025 /PRNewswire/ -- Addtronics, LLC ("Addtronics"), a consolidator of high-quality, niche automation technology and solution providers...
Why Diversity in Clinical Trials Is So Important
NORTHAMPTON, MA / ACCESSWIRE / January 6, 2025 / Clinical trials are essential for the development of health care products,...
Hemostemix Announces the Incorporation of Hemostemix PR Inc: 50% Reimbursement of R&D Expenses in Cash
Calgary, Alberta--(Newsfile Corp. - January 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
LONDON--(BUSINESS WIRE)--#cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Natalia Kozmina is joining the Company as...
Inovalon Completes Three-Year Transformation to Pure-Play Cloud-Based SaaS and DaaS Platform Provider
Divestiture of all legacy services and intervention operations completed, resulting in a 100% pure-play cloud-based SaaS and DaaS platform provider...
Inovalon Completes Three-Year Transformation to Pure-Play Cloud-Based SaaS and DaaS Platform Provider
Divestiture of all legacy services and intervention operations completed, resulting in a 100% pure-play cloud-based SaaS and DaaS platform provider...
Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
DENVER, CO / ACCESSWIRE / January 6, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company...
SterileCare Inc. Reaches Key Enrollment Milestone in Innovative Catheter Lock Solution Trial
dicentra congratulates SterileCare on achieving a significant milestone in their innovative catheter lock solution clinical trial, with 20 patients enrolled...
Penn Medicine Becker ENT & Allergy Features Castle Connolly Awarded Doctors in 2024
Celebrating excellence in ENT care with recognized physicians in New Jersey and Philadelphia. PRINCETON, NEW JERSEY / ACCESSWIRE / January...
AI/ML Innovations Inc. Announces Appointment of Peter Kendall as President and Chief Commercialization Officer
Accomplished Commercialization Leader to Drive Global Growth.Proven Expertise in Scaling Health Tech Businesses - Mr. Kendall Brings a Track Record...
NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
CARMEL, Ind., Jan. 06, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced...
Rendever Launches Alcove Sanctuary: A New VR Application Featuring an AI Family Companion
VR app features Nova, the new embodied AI companion that sparks conversation and adventure from the comfort of the homeBOSTON,...
Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week
SEATTLE and VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...
Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors
Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt Reports Unaudited...
Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference
JUPITER, Fla., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI),...
LB Pharmaceuticals Announces Presentation at the 43rd Annual J.P. Mogan Healthcare Conference
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the...
Ascendis Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
COPENHAGEN, Denmark, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate...